Cargando…
The screening power of methylenetetrahydrofolate reductase C677T polymorphism versus plasma homocysteine concentration in patients with stenosis of the internal carotid artery
BACKGROUND: Hyperhomocysteinemia is an important and independent risk factor for vascular disease. About 35% of patients with stroke and 47% of patients with peripheral arterial disease have elevated plasma homocysteine (HCY) concentrations. The relationship between plasma HCY and the methylentetrah...
Autores principales: | Loncar, Robert, Müller, Barbara T, Zotz, Reiner B, Sucker, Christof, Sandmann, Wilhelm, Scharf, Rüdiger E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586187/ https://www.ncbi.nlm.nih.gov/pubmed/16999862 http://dx.doi.org/10.1186/1477-9560-4-16 |
Ejemplares similares
-
Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in
psoriasis in southern Turkey
por: Izmirli, Muzeyyen, et al.
Publicado: (2016) -
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism and cognitive impairment: the health in men study
por: Ford, A H, et al.
Publicado: (2012) -
Homocysteine, methylenetetrahydrofolate reductase C677T polymorphism, and risk of retinal vein occlusion: an updated meta-analysis
por: Li, Dan, et al.
Publicado: (2014) -
Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes
por: Pollex, Rebecca L, et al.
Publicado: (2005) -
Thermolabile Methylenetetrahydrofolate Reductase C677T Polymorphism and Homocysteine Are Risk Factors for Coronary Artery Disease in Moroccan Population
por: Bennouar, Nawal, et al.
Publicado: (2007)